These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 6601046

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. A quantitative immunochemical faecal occult blood test is more efficient for detecting significant colorectal neoplasia than a sensitive guaiac test.
    Levi Z, Hazazi R, Rozen P, Vilkin A, Waked A, Niv Y.
    Aliment Pharmacol Ther; 2006 May 01; 23(9):1359-64. PubMed ID: 16629942
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Comparison of predictive value for colorectal cancer in subjects with and without rectal bleeding.
    Nakama H, Kayano T, Katsuura T, Kamigaito T, Shimada S, Nishikawa N, Yoshii S, Kamijo N.
    Hepatogastroenterology; 1999 May 01; 46(27):1730-2. PubMed ID: 10430332
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Does prolonging the test period improve screening for colorectal cancer?].
    Hammes PH, Gnauck R.
    Z Gastroenterol; 1987 Sep 01; 25(9):607-11. PubMed ID: 3673146
    [Abstract] [Full Text] [Related]

  • 31. Immunological detection of faecal occult blood in colorectal cancer.
    Turunen MJ, Liewendahl K, Partanen P, Adlercreutz H.
    Br J Cancer; 1984 Feb 01; 49(2):141-8. PubMed ID: 6696817
    [Abstract] [Full Text] [Related]

  • 32. Lower gastrointestinal symptoms are not predictive of colorectal neoplasia in a faecal occult blood screen-positive population.
    Ahmed S, Leslie A, Thaha MA, Carey FA, Steele RJ.
    Br J Surg; 2005 Apr 01; 92(4):478-81. PubMed ID: 15609377
    [Abstract] [Full Text] [Related]

  • 33. Five guaiac-based tests for occult blood in faeces compared in vitro and in vivo.
    Adlercreutz H, Partanen P, Virkola P, Liewendahl K, Turunen MJ.
    Scand J Clin Lab Invest; 1984 Oct 01; 44(6):519-28. PubMed ID: 6333067
    [Abstract] [Full Text] [Related]

  • 34. [The guaiac test and colorectal pathology. Clinical evaluation].
    Angelici A, Piermattei A, Palumbo P, Turano R, Vietri F.
    Minerva Chir; 1993 Mar 31; 48(6):273-6. PubMed ID: 8506047
    [Abstract] [Full Text] [Related]

  • 35. The detection of asymptomatic colorectal cancer.
    Miller SF.
    Am Fam Physician; 1978 Sep 31; 18(3):89-92. PubMed ID: 685802
    [Abstract] [Full Text] [Related]

  • 36. Assessment of faecal occult blood loss by qualitative and quantitative methods.
    Barber MD, Abraham A, Brydon WG, Waldron BM, Williams AJ.
    J R Coll Surg Edinb; 2002 Apr 31; 47(2):491-4. PubMed ID: 12018693
    [Abstract] [Full Text] [Related]

  • 37. [Population screening for colon and rectum cancer using the Hemoccult test].
    van Tongeren JH.
    Ned Tijdschr Geneeskd; 1982 Oct 23; 126(43):1967-9. PubMed ID: 7177204
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Interval cancers in a randomized controlled trial of screening for colorectal cancer using a faecal occult blood test.
    Moss SM, Hardcastle JD, Coleman DA, Robinson MH, Rodrigues VC.
    Int J Epidemiol; 1999 Jun 23; 28(3):386-90. PubMed ID: 10405838
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.